The Study of Delay Discounting Among Beneficiaries of the Pé-de-Meia Program
Launched by FEDERAL INSTITUTE OF EDUCATION, SCIENCE AND TECHNOLOGY OF THE STATE OF MATO GROSSO · Mar 25, 2024
Trial Information
Current as of July 05, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a program called "Pé-de-Meia" impacts high school students from low-income families in Brazil. The program aims to help these students stay in school and complete their studies. The researchers want to understand if this program influences the students' ability to wait for a reward, which is known as "delay discounting." In simpler terms, they are exploring whether students who participate in this program are better at making long-term decisions and how this might relate to their school performance and attendance.
To be eligible for this study, students must be enrolled in public high schools and come from low-income families. However, students with a psychological or psychiatric diagnosis will not be included. If selected to participate, students will take part in assessments to measure their decision-making skills and their academic results will be tracked over time. This research aims to shed light on how support programs like "Pé-de-Meia" can benefit students' education and future choices.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • High school students, Students from public schools; Students from low-income families. -
- Exclusion Criteria:
- • Students with a formal psychological report; students with a formal psychiatric report.
- • -
About Federal Institute Of Education, Science And Technology Of The State Of Mato Grosso
The Federal Institute of Education, Science and Technology of the State of Mato Grosso (IFMT) is a prominent educational and research institution dedicated to advancing knowledge and innovation in the fields of education and technology. Committed to fostering scientific research and development, IFMT actively engages in clinical trials aimed at improving public health outcomes and enhancing community well-being. With a focus on collaboration and ethical standards, the institute leverages its academic expertise and resources to contribute to the advancement of medical science, ensuring rigorous methodologies and impactful findings that benefit both local and broader populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported